+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin



Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin



European Journal of Clinical Pharmacology 24(5): 639-642



The influence of age on amikacin pharmacokinetics was examined in 87 patients with normal renal function. All patients had a gram negative infection, were febrile, weighed within 20% of their ideal body weight, did not receive penicillin antibiotics concurrently, had normal hematocrits and had a measured 24 h creatinine clearance greater than 80 ml/min/1.73 m2. 31 patients were 20-39 years old, 27 patients were between the ages of 40-59 years, and 29 patients were 60-79 years old. These patients were compared to patients in similar previous studies who received gentamicin or tobramycin. No significant differences in clearance, volume of distribution or half-life were found due to age within a single drug group (amikacin, gentamicin, or tobramycin) or among the 3 drug groups. However, a substantial amount of intersubject variability existed in the calculated pharmacokinetic parameters. Patients over 40 years old tended to be underdosed with amikacin and the other 2 aminoglycosides. The average amikacin dose needed to achieve the desired steady-state concentrations was 18.9 mg/kg/day. 52% of the amikacin patients required doses greater than the recommended maximum (15 mg/kg/day). Since aminoglycoside pharmacokinetics do not change as age increases, doses do not need to be arbitrarily changed in older patients with normal renal function.

(PDF emailed within 0-6 h: $19.90)

Accession: 043395296

Download citation: RISBibTeXText

PMID: 6873143

DOI: 10.1007/bf00542214


Related references

Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin. Journal of Infectious Diseases 134(Suppl.): S200-S205, 1976

Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin. Antimicrobial Agents and ChemoTherapy 18(2): 338-345, 1980

Effect of ticarcillin on gentamicin and tobramycin pharmacokinetics in a patient with end-stage renal disease. PharmacoTherapy 4(3): 158-160, 1984

Early monitoring of urinary RBP for renal damage of gentamicin, amikacin and tobramycin. Zhongguo Kangshengsu Zazhi 24(2): 149;155, 1999

Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans. Antimicrobial Agents and ChemoTherapy 27(4): 520-524, 1985

Comparison of the bactericidal activity of three aminosides: gentamicin, tobramycin and amikacin. Pathologie-Biologie 35(5): 461-465, 1987

The in vitro activity of netromycin in comparison with gentamicin tobramycin and amikacin. Zhongguo Kanfshengsu Zazhi 12(6): 411-416, 1987

Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin. Expert Review of Anti-Infective Therapy 10(4): 459-473, 2012

Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin. British Medical Journal 3(5934): 778-780, 1974

Influence of endotoxin on the intrarenal distribution of gentamicin, netilmicin, tobramycin, amikacin, and cephalothin. Antimicrobial Agents and ChemoTherapy 29(1): 7-12, 1986

Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin. Annales de Microbiologie 130a(3): 331-343, 1979

The nephro toxicity and renal accumulation of amikacin tobramycin and gentamicin in rats rabbits and guinea pigs. Experimentelle Pathologie 15(6): 370-375, 1978

Reproducibility study of the pharmacokinetics of amikacin, gentamicin and tobramycin; a three-way crossover study. Journal of Antimicrobial ChemoTherapy 12(4): 371-376, 1983

Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns. Arzneimittel-Forschung 30(3): 491-495, 1980

Enterobacteria isolated in hospitals. Comparison of the bacteriostatic and bactericidal activity of amikacin, gentamicin and tobramycin. La Nouvelle Presse Medicale 8(42): 3399-3402, 1979